Tudor Investment Corp’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Tudor Investment Corp’s Portfolio CALT Stock Details CALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-65	Closed	-$1.37K	–	2904
2024 Q1	$1.37K	Buy	+65	New	+$1.45K	﹤0.01%	2142
2021 Q2	–	Sell	-13,782	Closed	-$380K	–	2017
2021 Q1	$380K	Buy	+13,782	New	+$412K	0.01%	1225
2020 Q4	–	Sell	-24,422	Closed	-$586K	–	1689
2020 Q3	$586K	Sell	24,422 -10,730	-31%	-$250K	0.03%	752
2020 Q2	$816K	Buy	+35,152	New	+$696K	0.04%	543

Other funds holding CALT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

IIM

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCMC

Planning Capital Management Corporation Paoli, Pennsylvania $151M AUM 30.62% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tudor Investment Corp's CALT Position: Q2 2024 in Review

Tudor Investment Corp sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q2 2024, closing a stake of 65 shares — an estimated $1.37K sold.

Tudor Investment Corp first reported a position in CALT in Q2 2020 and held it in 4 quarters. The position peaked at $816K in Q2 2020. 18 funds tracked by Wall St. Rank hold CALT as of Q2 2024.

Tudor Investment Corp reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q2 2024 after selling out during the quarter.
Tudor Investment Corp sold 65 Calliditas Therapeutics AB American Depositary Shares shares in Q2 2024, an estimated $1.37K.
Tudor Investment Corp first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2020 and held it in 4 quarters.
Tudor Investment Corp's Calliditas Therapeutics AB American Depositary Shares position peaked at $816K in Q2 2020.
18 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.